Search filters

List of works by Julianne Chen

Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation

scientific article published on 31 March 2015

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation

scientific article published on 8 January 2018

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study

scientific article

Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?

scientific article

Curative potential of hematopoietic stem cell transplantation for advanced psoriasis

scientific article published on 03 April 2019

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia

scientific article published on 30 June 2020

Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation

scientific article published on 09 February 2020

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

scientific article published on 16 March 2015

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

scientific article published on 12 May 2017

Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission

scientific article

Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial

scientific article published on 01 November 2018

General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation

scientific article published on 20 February 2015

Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

scientific article published on 13 September 2017

Haploidentical Transplants for Patients with Graft Failure After the First Allograft

scientific article published on 29 June 2020

Haploidentical Transplants for Patients with Relapse After the First Allograft

scientific article published on 03 July 2020

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity

scientific article published on 01 April 2020

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes

scientific article published on 24 August 2017

Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome

scientific article published on 26 September 2018

Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation

scientific article published on 27 February 2020

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

scientific article

Is a matched unrelated donor search needed for all allogeneic transplant candidates?

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

scientific article published on 01 February 2020

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation

scientific article published on 13 April 2015

Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.

scientific article published on July 2016

Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

scientific article

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial

scientific article published on 04 April 2019

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation

scientific article published on 10 September 2019

Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation

scientific article

Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.

scientific article published on 21 December 2017

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

scientific article published on 7 February 2015

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

scientific article published on 18 October 2018

Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

scientific article

Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia

scientific article published on 18 August 2016

Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation.

scientific article published on 28 March 2017

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

scientific article published on 16 May 2018

Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS

scientific article published on 10 December 2018

Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation

scientific article published on 4 January 2017

Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

scientific article published on 12 July 2016

Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes

scientific article published on 26 February 2020

Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission

scientific article

Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

scientific article

Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib

scientific article

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia

scientific article published on 04 September 2015